arrow
N

Noa G. Holtzman

sylvester comprehensive cancer center
H指数:12
被引数:656

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

达沙替尼暴露与费城染色体阳性急性淋巴细胞白血病中巨细胞病毒再激活风险

2026-07-290
OAAI
Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 study.

巴瑞替尼治疗难治性慢性移植物抗宿主病:一项1/2期研究的结果

2026-05-280
OAAI
Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era

侵袭性曲霉菌病在血液恶性肿瘤及移植和细胞疗法患者中的临床特征与当代结局

2026-02-050
OAAI
Cytomegalovirus Lymphadenitis Mimicking Relapsed Lymphoma After CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy

巨细胞病毒淋巴结炎模拟CD19嵌合抗原受体(CAR)T细胞疗法后复发的淋巴瘤

Apmis
IF2.6
2026-02-010
PRE
Extracorporeal Photopheresis for Chronic Graft-Versus-Host Disease According to 2014 NIH Consensus Criteria

根据2014年NIH共识标准的外周血光分离置换疗法治疗慢性移植物抗宿主病

2025-11-230
OAAI
Psychosocial correlates of failure to complete hematopoietic stem cell transplants in a diverse population

造血干细胞移植未完成的心理社会相关因素研究:一项针对多样化人群的调查

2025-06-020
PRE
Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT

I期/II期高剂量palifermin用于HLA匹配无关供者HCT患者GVHD预防的研究

Blood
IF23.1
2025-05-090
PRE
Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study

贝卢莫苏迪尔减轻口腔慢性移植物抗宿主病组织炎症和纤维化:一项ROCKstar伴侶研究

2025-05-050
OA
Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease

Janus激酶抑制剂Baricitinib在眼部慢性移植物抗宿主病中的全身治疗

2025-01-010
OAAI
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
2024-08-151
OAAI